GeneBioTech Co. Ltd Financial Flexibility Index
GeneBioTech Co. Ltd financial flexibility index. GeneBioTech Co. Ltd (086060) has a Financial Flexibility Index of 0.00x as of June 2026. Free cash flow of ₩21.17 Million (operating CF ₩-230.73 Million minus capex ₩251.90 Million) represents 0% of total liabilities (₩24.02 Billion). See 086060 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of GeneBioTech Co. Ltd (2009–2025)
Financial flexibility index of GeneBioTech Co. Ltd from 2009 to 2025. Historical Financial Flexibility Index trend for GeneBioTech Co. Ltd across 16 annual periods. Check GeneBioTech Co. Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
GeneBioTech Co. Ltd Financial Flexibility Index by Year (2009–2025)
GeneBioTech Co. Ltd financial flexibility index by year from 2009 to 2025. Year-by-year free cash flow to debt coverage for GeneBioTech Co. Ltd. For the full cash flow conversion analysis, see 086060 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | ₩11.37 Billion | ₩7.61 Billion | ₩20.64 Billion | ▲ +1510.1% |
| 2024 | 0.03x | ₩719.33 Million | ₩-463.87 Million | ₩21.02 Billion | ▼ -92.5% |
| 2023 | 0.46x | ₩8.14 Billion | ₩7.37 Billion | ₩17.71 Billion | ▲ +435.8% |
| 2022 | -0.14x | ₩-2.50 Billion | ₩-3.68 Billion | ₩18.31 Billion | ▼ -960.1% |
| 2021 | 0.02x | ₩261.15 Million | ₩-2.84 Billion | ₩16.42 Billion | ▼ -96.1% |
| 2020 | 0.40x | ₩6.88 Billion | ₩2.49 Billion | ₩17.04 Billion | ▲ +2141.8% |
| 2019 | -0.02x | ₩-415.17 Million | ₩-2.68 Billion | ₩21.00 Billion | ▼ -107.5% |
| 2018 | 0.26x | ₩6.51 Billion | ₩5.96 Billion | ₩24.66 Billion | ▲ +124.7% |
| 2017 | 0.12x | ₩2.24 Billion | ₩1.13 Billion | ₩19.05 Billion | ▼ -64.2% |
| 2016 | 0.33x | ₩6.61 Billion | ₩5.31 Billion | ₩20.14 Billion | ▲ +89.3% |
| 2015 | 0.17x | ₩3.53 Billion | ₩2.61 Billion | ₩20.37 Billion | ▲ +55.6% |
| 2014 | 0.11x | ₩2.67 Billion | ₩2.15 Billion | ₩23.92 Billion | ▼ -5.0% |
| 2013 | 0.12x | ₩2.96 Billion | ₩2.38 Billion | ₩25.25 Billion | ▼ -37.7% |
| 2011 | 0.19x | ₩5.04 Billion | ₩2.53 Billion | ₩26.79 Billion | ▲ +13.2% |
| 2010 | 0.17x | ₩1.86 Billion | ₩1.17 Billion | ₩11.18 Billion | ▼ -35.6% |
| 2009 | 0.26x | ₩2.91 Billion | ₩2.68 Billion | ₩11.28 Billion | — |